Cargando…

Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023

Although lymph node dissection (LND) during radical nephroureterectomy (RNU) is recommended for high-risk nonmetastatic upper tract urothelial carcinoma (UTUC), adherence to guidelines remains insufficient in clinical practice. Therefore, this review aims to comprehensively summarize the current evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagisawa, Takafumi, Kawada, Tatsushi, von Deimling, Markus, Laukhtina, Ekaterina, Kimura, Takahiro, Shariat, Shahrokh F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256309/
https://www.ncbi.nlm.nih.gov/pubmed/37014743
http://dx.doi.org/10.1097/MOU.0000000000001097
_version_ 1785057075723763712
author Yanagisawa, Takafumi
Kawada, Tatsushi
von Deimling, Markus
Laukhtina, Ekaterina
Kimura, Takahiro
Shariat, Shahrokh F.
author_facet Yanagisawa, Takafumi
Kawada, Tatsushi
von Deimling, Markus
Laukhtina, Ekaterina
Kimura, Takahiro
Shariat, Shahrokh F.
author_sort Yanagisawa, Takafumi
collection PubMed
description Although lymph node dissection (LND) during radical nephroureterectomy (RNU) is recommended for high-risk nonmetastatic upper tract urothelial carcinoma (UTUC), adherence to guidelines remains insufficient in clinical practice. Therefore, this review aims to comprehensively summarize the current evidence regarding the diagnostic, prognostic, and therapeutic impact of LND during RNU in UTUC patients. RECENT FINDINGS: Clinical nodal staging using conventional CT scan has low sensitivity (25%) and diagnostic accuracy [area under the curve (AUC): 0.58] in UTUC, suggesting the importance of LND for obtaining accurate N-staging. Patients with pathological node-positive (pN+) disease have poor disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) compared with those with pN0. In addition, population-based studies showed that patients who underwent LND improved CSS and OS than those who did not, even in patients who received adjuvant systemic therapy. The number of lymph nodes removed has also been shown to be associated with improved CSS and OS, even in pT0 patients. Template-based LND should be performed as the extent of lymph node is more important than the number of lymph nodes. Robot-assisted RNU may facilitate performing a meticulous LND compared with a laparoscopic approach. Postoperative complications such as lymphatic and/or chylous leakage are increased but adequately manageable. However, the current evidence is not supported by high-quality studies. SUMMARY: Based on the published data, LND during RNU is a standard procedure for high-risk nonmetastatic UTUC, owing to its diagnostic, staging, prognostic, and, potentially, therapeutic benefits. Template-based LND should be offered to all patients who are planned for RNU for high-risk nonmetastatic UTUC. Patients with pN+ disease are optimal candidates for adjuvant systemic therapy. Robot-assisted RNU may facilitate meticulous LND compared with laparoscopic RNU.
format Online
Article
Text
id pubmed-10256309
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102563092023-06-10 Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023 Yanagisawa, Takafumi Kawada, Tatsushi von Deimling, Markus Laukhtina, Ekaterina Kimura, Takahiro Shariat, Shahrokh F. Curr Opin Urol MANAGEMENT OF LYMPH NODES IN UROLOGY: Edited by Richard Matulewicz and Jeremy Teoh Although lymph node dissection (LND) during radical nephroureterectomy (RNU) is recommended for high-risk nonmetastatic upper tract urothelial carcinoma (UTUC), adherence to guidelines remains insufficient in clinical practice. Therefore, this review aims to comprehensively summarize the current evidence regarding the diagnostic, prognostic, and therapeutic impact of LND during RNU in UTUC patients. RECENT FINDINGS: Clinical nodal staging using conventional CT scan has low sensitivity (25%) and diagnostic accuracy [area under the curve (AUC): 0.58] in UTUC, suggesting the importance of LND for obtaining accurate N-staging. Patients with pathological node-positive (pN+) disease have poor disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) compared with those with pN0. In addition, population-based studies showed that patients who underwent LND improved CSS and OS than those who did not, even in patients who received adjuvant systemic therapy. The number of lymph nodes removed has also been shown to be associated with improved CSS and OS, even in pT0 patients. Template-based LND should be performed as the extent of lymph node is more important than the number of lymph nodes. Robot-assisted RNU may facilitate performing a meticulous LND compared with a laparoscopic approach. Postoperative complications such as lymphatic and/or chylous leakage are increased but adequately manageable. However, the current evidence is not supported by high-quality studies. SUMMARY: Based on the published data, LND during RNU is a standard procedure for high-risk nonmetastatic UTUC, owing to its diagnostic, staging, prognostic, and, potentially, therapeutic benefits. Template-based LND should be offered to all patients who are planned for RNU for high-risk nonmetastatic UTUC. Patients with pN+ disease are optimal candidates for adjuvant systemic therapy. Robot-assisted RNU may facilitate meticulous LND compared with laparoscopic RNU. Lippincott Williams & Wilkins 2023-07 2023-04-03 /pmc/articles/PMC10256309/ /pubmed/37014743 http://dx.doi.org/10.1097/MOU.0000000000001097 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle MANAGEMENT OF LYMPH NODES IN UROLOGY: Edited by Richard Matulewicz and Jeremy Teoh
Yanagisawa, Takafumi
Kawada, Tatsushi
von Deimling, Markus
Laukhtina, Ekaterina
Kimura, Takahiro
Shariat, Shahrokh F.
Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
title Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
title_full Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
title_fullStr Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
title_full_unstemmed Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
title_short Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
title_sort need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
topic MANAGEMENT OF LYMPH NODES IN UROLOGY: Edited by Richard Matulewicz and Jeremy Teoh
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256309/
https://www.ncbi.nlm.nih.gov/pubmed/37014743
http://dx.doi.org/10.1097/MOU.0000000000001097
work_keys_str_mv AT yanagisawatakafumi needforandextentoflymphnodedissectionforuppertracturothelialcarcinomaanupdatedreviewin2023
AT kawadatatsushi needforandextentoflymphnodedissectionforuppertracturothelialcarcinomaanupdatedreviewin2023
AT vondeimlingmarkus needforandextentoflymphnodedissectionforuppertracturothelialcarcinomaanupdatedreviewin2023
AT laukhtinaekaterina needforandextentoflymphnodedissectionforuppertracturothelialcarcinomaanupdatedreviewin2023
AT kimuratakahiro needforandextentoflymphnodedissectionforuppertracturothelialcarcinomaanupdatedreviewin2023
AT shariatshahrokhf needforandextentoflymphnodedissectionforuppertracturothelialcarcinomaanupdatedreviewin2023